iBio logo

iBio

IBIO | NASDAQ
Chart Builder DCF Calculator
$0.71
-$0.02 (-2.97%)
At close: Nov 16, 2026, 4:00 PM ET
$0.69
-$0.02 (-2.11%)
After-hours: Nov 16, 2026, 7:55 PM ET
-2.97%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
41.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #490/1021 (Top 48%)

Key Statistics

Market Data

Market Cap $107.62M
1D Range
0.68 0.77
52W Range
0.68 3.07

Valuation (TTM)

PE -2.54
PB 1.37
EV/EBITDA -0.97

Valuation (NTM)

Forward PE N/A
Forward PEG 3.78
Price Target $5.00
Loading financial charts...

Profile

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two ...

Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date Aug 19, 2008
Fiscal Year July - June

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.05
Beat +28.57%
REV
$1.1M
Beat +4300.00%
Next Earnings
Feb 9, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+604.23%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.